Toggle Main Menu Toggle Search

Open Access padlockePrints

Browsing publications by Dr Susan Tudhope.

Newcastle AuthorsTitleYearFull text
Dr Evan Mulligan
Dr Susan Tudhope
Dr Jill Hunter
Sarah Elliott
Dr Jonathan Wallis
et al.
Expression and Activity of the NF-κB Subunits in Chronic Lymphocytic Leukaemia: A Role for RelB and Non-Canonical Signalling2023
Catherine Salvini
Benoit Darlot
Jack Davison
Dr Mathew Martin
Dr Susan Tudhope
et al.
Fragment expansion with NUDELs – poised DNA-encoded libraries2023
Islam Al-Khawaldeh
Dr Christine Basmadjian
Dr Cinzia Bordoni
Dr Suzannah Harnor
Amy Heptinstall
et al.
An alkynylpyrimidine-based covalent inhibitor that targets a unique cysteine in NF-κB-inducing kinase (NIK)2021
Dr Timothy Barrow
Dr Sirintra Nakjang
Kateryna Bilotkach
Dr Laura Woodhouse
Gesa Junge
et al.
Epigenome-wide analysis reveals functional modulators of drug sensitivity and post-treatment survival in chronic lymphocytic leukaemia2021
Dr Catherine Willoughby
Huw Thomas
Dr Elaine Willmore
Suzanne Kyle
Dr Anita Wittner
et al.
Selective DNA-PKcs Inhibition Extends the Therapeutic Index of Localized Radiotherapy and Chemotherapy2019
Christopher Coxon
Dr Suzannah Harnor
Dr Mathew Martin
Dr Benoit Carbain
Emeritus Professor Bernard Golding
et al.
Cyclin-Dependent Kinase (CDK) Inhibitors; Structure-Activity Relationships and Insights into the CDK-2 Selectivity of 6-Substituted 2-Arylaminopurines2017
Dr Ziad Al-Oanzi
Sofia Fountana
Tabassum Moonira
Dr Susan Tudhope
John Petrie
et al.
Opposite effects of a glucokinase activator and metformin on glucose-regulated gene expression in hepatocytes2017
Dr Timothy Barrow
Dr Laura Woodhouse
Gesa Junge
Dr Susan Tudhope
Dr Jonathan Wallis
et al.
The Role of HOXA4 in Chronic Lymphocytic Leukaemia Progression and Response to Therapy2016
Dr Elaine Willmore
Dr Aaron Ions Gardner
Dr Susan Tudhope
Belinda Murtani
Jessica Caffry
et al.
Novel small molecule IKK alpha inhibitors inhibit non- canonical NF-kappa B signaling and survival of primary CLL cells2015
Dr Ashleigh Herriott
Dr Susan Tudhope
Gesa Junge
Natalie Rodrigues
Dr Miranda Patterson
et al.
PARP1 expression, activity and ex vivo sensitivity to the PARP inhibitor, talazoparib (BMN 673), in Chronic Lymphocytic Leukaemia2015
Dr Helen Marr
Dr Luke Gaughan
Dr Susan Tudhope
Professor James Allan
Regulation of CD38 in IRF4 in Chronic Lymphocytic Leukaemia2015
Dr Susan Tudhope
Dr Yan Zhao
Dr Anita Wittner
Annalisa Bertoli
Santosh Adhikari
et al.
Profiling inhibitors of MDM2: p53 and MDMX: p53 in relation to MDMX protein levels2014
Dr Alessio Iannetti
Dr Adeline Ledoux
Dr Susan Tudhope
Helene Sellier
Adam Moore
et al.
Regulation of p53 and Rb Links the Alternative NF-kappaB Pathway to EZH2 Expression and Cell Senescence2014
Annalisa Bertoli
Santosh Adhikari
Dr Suzannah Harnor
Dr Yan Zhao
Professor John Lunec
et al.
Validation studies with small-molecule modulators of the MDM2/MDMX-p53 binding interaction2014
Dr John Petrie
Dr Ziad Al-Oanzi
Dr Catherine Arden
Dr Susan Tudhope
Professor Jelena Mann
et al.
Glucose induces protein targeting to glycogen in hepatocytes by fructose 2,6-bisphosphate-mediated recruitment of MondoA to the promoter2013
Dr Susan Tudhope
Dr Fiona Malcomson
Dr Catherine Arden
Dr Laura Hampson
Professor Loranne Agius
et al.
A Novel Mechanism for Regulating Hepatic Glycogen Synthesis Involving Serotonin and Cyclin-Dependent Kinase-52012
Dr Catherine Arden
Dr Susan Tudhope
Dr Ziad Al-Oanzi
Kirsty Cullen
Professor Loranne Agius
et al.
Fructose 2,6-bisphosphate is essential for glucose-regulated genetranscription of glucose-6-phosphatase and other ChREBP target genes inhepatocytes2012
Dr Susan Tudhope
Dr Evan Mulligan
Dr Jill Hunter
Dr Helen Marr
Professor barbara Durkacz
et al.
P B S-1086, a "Pan-Rel" Inhibitor, Decreases Viability of Chronic Lymphocytic Leukemia Cells2012
Dr Ziad Al-Oanzi
Dr John Petrie
Dr Susan Tudhope
Dr Catherine Arden
Professor Loranne Agius
et al.
The insulin-independent glucose-induction of the hepatic gluconeogenic enzyme glucose 6-phosphatase involves distinct metabolic pathways and transcription factors2012
Dr Catherine Arden
Dr Susan Tudhope
Dr Ziad Al-Oanzi
Professor Loranne Agius
Elevated glucose represses liver glucokinase and induces its regulatory protein to safeguard hepatic phosphate homeostasis2011
Professor Fai Ng
Dr Susan Tudhope
Dr Alexei von Delwig
Dr Desa Lilic
Invariant natural killer T (iNKT) cell deficiency in chronic mucocutaneous candidiasis - A consequence or a cause?2011
Dr Susan Tudhope
Dr Alexei von Delwig
Dr Jane Falconer
Dr Arthur Pratt
Professor John Isaacs
et al.
Profound invariant natural killer T-cell deficiency in inflammatory arthritis2010
Dr Alexei von Delwig
Dr Arthur Pratt
Dr Susan Tudhope
Professor John Isaacs
Professor Fai Ng
et al.
Invariant natural killer T (iNKT) cells in early rheumatoid arthritis (RA)2008
Dr Alexei von Delwig
Dr Susan Tudhope
Dr Arthur Pratt
Professor John Isaacs
Dr Desa Lilic
et al.
The role of invariant natural killer T (iNKT) cells in rheumatoid arthritis2008